Nature punished Kerala through floods for eating beef, claims Karnataka BJP MLA

Thiruvananthapuram, Jun 25: The government of Kerala under the leadership of Chief Minister Pinarayi Vijayan is all set to launch the 'Kerala Dialogue' -- a debate series on new concepts and development models during the COVID-19 pandemic.

A series of visionaries including noted political thinker Noam Chomsky and Nobel-laureate economist Amartya Sen will join this unique initiative that is to be rolled out from Friday.

The debate series to be inaugurated by the CM will feature prominent personalities from various walks of life including scientists, philosophers, diplomats, economists, writers, journalists, activists, technocrats and people's representatives.

The first episode will have Chomsky, Sen and WHO Chief Scientist Dr Soumya Swaminathan speaking on 'Kerala - Future Paths of Development'. 

State Planning Board vice chairman VK Ramachandran and senior journalist N Ram would be the moderators. The first episode would be telecast through the Chief Minister's official social media accounts.

The coming episodes in the series will also be telecast in the same manner. The government is of the view that the Kerala Dialogue series can ensure debates and dialogues on sustainable and inclusive development on the lines of the Kerala model.

Bengaluru, May 13: The Karnataka Common Entrance Test (K-CET) 2020 will be held on July 30 and 31.

The test, earlier as scheduled to be held on April 22, 23 and 24, was postponed due to COVID-19 crisis and the nation-wide lockdown.

Now, considering the dates for National Eligibility cum Entrance Test (NEET) and Joint Entrance Examination (JEE) dates announced by the Union government, the state government has announced the revised dates on Wednesday.

Higher Education Minister Dr C N Ashwath Narayan announced this in a press conference. The test will be held online, the minister said. 

For CET 2020, over 1.90 lakh students registered for admission to undergraduate engineering, B Tech, Architecture, Agriculture and veterinary science courses.

Home quarantine for repatriated pregnant women, children, senior citizens if they test covid-19 negative 

The Union Health Ministry has revised its discharge guidelines for COVID-19 patients, stating that only those with severe illness need to be tested (through a swab test) and a negative report needs to be obtained before discharge.

The latest guideline adds that other categories of patients, including very mild, mild, pre-symptomatic and moderate cases, need not be tested before discharge.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.